Clinical Trial Update: Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety of Brimonidine Tartrate Ophthalmic Solution across pediatric, adult, and geriatric participants completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperemia

Drugs mentioned

• brimonidine tartrate ophthalmic solution (brimonidine tartrate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Hyperemia | Phase 3 | Status: COMPLETED | Results posted: 2019-10-23